Effect of Compound Sophorae Decoction on inflammatory factors and autophagy levels in colonic tissue of mice with ulcerative colitis

DENG Shuangjiao; ZUO Dongmei; CHEN Qianyun; LIU Yujin; LI Huarong

doi:10.16305/j.1007-1334.2023.2210040

您当前的位置：

首页 >

文章列表页 >

Effect of Compound Sophorae Decoction on inflammatory factors and autophagy levels in colonic tissue of mice with ulcerative colitis

更新时间：2023-08-28

- Effect of Compound Sophorae Decoction on inflammatory factors and autophagy levels in colonic tissue of mice with ulcerative colitis
- Shanghai Journal of Traditional Chinese Medicine Vol. 57, Issue 9, Pages: 63-69(2023)
- 作者机构：
  
  1.华中科技大学同济医学院附属协和医院中西医结合科（湖北武汉 430022）；2.华中科技大学协和京山医院中医科（湖北荆门 431800）
  2.Department of Traditional Chinese Medicine， Jingshan Union Hospital， Huazhong University of Science and Technology， Jingmen， Hubei 431800， China
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2023.2210040
  CLC：
扫描看全文
邓双娇,左冬梅,陈倩云,等.复方苦参汤对溃疡性结肠炎小鼠结肠组织中炎症因子及自噬水平的影响[J].上海中医药杂志,2023,57(9):63-69.

DENG Shuangjiao,ZUO Dongmei,CHEN Qianyun,et al.Effect of Compound Sophorae Decoction on inflammatory factors and autophagy levels in colonic tissue of mice with ulcerative colitis[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(9):63-69.
邓双娇,左冬梅,陈倩云,等.复方苦参汤对溃疡性结肠炎小鼠结肠组织中炎症因子及自噬水平的影响[J].上海中医药杂志,2023,57(9):63-69. DOI： 10.16305/j.1007-1334.2023.2210040.

DENG Shuangjiao,ZUO Dongmei,CHEN Qianyun,et al.Effect of Compound Sophorae Decoction on inflammatory factors and autophagy levels in colonic tissue of mice with ulcerative colitis[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(9):63-69. DOI： 10.16305/j.1007-1334.2023.2210040.

摘要

目的,2,观察复方苦参汤对溃疡性结肠炎（UC）小鼠结肠组织中炎症因子及自噬水平的影响，并探讨其作用机制。,方法,2,将20只SPF级C57BL/6雄性小鼠随机分为正常组、模型组、复方苦参汤组、美沙拉嗪组，每组5只。适应性喂养7 d后，除正常组外，其余3组予以3%葡聚糖硫酸钠（DSS）自由饮用7 d制备UC小鼠模型。同时在造模第1天开始，正常组和模型组每日均以质量分数为0.9%的氯化钠溶液灌胃，复方苦参汤组与美沙拉嗪组分别予复方苦参汤（7.28 g/kg）、美沙拉嗪（0.52 g/kg）灌胃，每日1次，连续灌胃7 d。每天记录小鼠体质量、大便性状及便血情况，进行疾病活动指数（DAI）评分。末次灌胃结束后，取各组小鼠结肠组织，测量结肠长度，肉眼观察肠黏膜炎症损伤程度进行结肠黏膜损伤指数（CMDI）评分。采用苏木精-伊红染色（HE）法观察结肠组织病理变化，酶联免疫吸附试验（ELISA）检测白介素-1β（IL-1β）、白介素-18（IL-18）含量；免疫印迹（Western blot）法及实时荧光定量逆转录聚合酶链式反应（RT-qPCR）法检测自噬相关分子蛋白及mRNA表达。,结果,2,与正常组比较，模型组大鼠DAI评分、CMDI评分、促炎因子IL-1β和IL-18，以及泛素结合蛋白 P62（P62）分子表达升高（,P,<,0.05），结肠长度缩短（,P,<,0.05），而抑炎因子白介素-4（IL-4）、白介素-10（IL-10）的表达下降（,P,<,0.05），Bcl-2同源结构域（Beclin1）蛋白、微管相关蛋白1A/1B轻链3（LC3）蛋白和其mRNA的表达水平明显降低（,P,<,0.05）。与模型组比较，复方苦参汤组与美沙拉嗪组的DAI评分、CMDI评分、促炎因子IL-1β和IL-18，以及P62分子均表达降低（,P,<,0.05），结肠长度显著增加（,P,<,0.05），而抑炎因子IL-4和IL-10，以及Beclin1、LC3的表达水平明显升高（,P,<,0.05）。与美沙拉嗪组比较，复方苦参汤组的CMDI评分增加（,P,<,0.05），IL-1β、IL-18及P62的表达均升高（,P,<,0.05），而IL-4、IL-10，Beclin1、LC3的表达降低（,P,<,0.05），同时结肠长度以及DAI评分差异无统计学意义（,P,>,0.05）。,结论,2,复方苦参汤可通过促进肠组织自噬的表达，减轻UC结肠炎症反应及病理损伤。

Abstract

Objective,2,To observe the effect of Compound Sophorae Decoction （CSD） on inflammatory factors and autophagy in colon tissue of mice with ulcerative colitis （UC）， and to explore its mechanism of action.,Methods,2,Twenty SPF C57BL/6 male mice were randomly divided into normal group， model group， CSD group and mesalazine group， with 5 mice in each group. After one week of adaptive feeding， UC mouse models were prepared by giving 3% dextran sulfate sodium （DSS） ad libitum for 1 week to mice in all three groups except the normal group. From the first day of modeling， the normal and model groups were intragastrically administered with 0.9% sodium chloride solution by mass fraction daily， and the CSD group and the mesalazine group were intragastrically administered once daily for 1 week with CSD （7.28 g/kg） and mesalazine （0.52 g/kg） respectively. Body weight， stool characteristics and hematochezia were recorded every day， and disease activity index （DAI） scores were measured. After the final gavage， the colonic tissues of mice in each group were taken to measure the length of the colon， and the degree of intestinal mucosal inflammatory injury was macroscopically observed for CMDI scoring. HE staining was used to observe the histopathological changes， ELISA was used to detect the contents of IL-1β and IL-18， and Western blot and RT-qPCR were used to detect autophagy-related molecule protein and mRNA expression.,Results,2,According to the inter-group comparison between normal group and model group， the DAI score， CMDI score， the expression of pro-inflammatory cytokines IL-1β， IL-18 and P62 molecules increased （,P,<,0.05）， the colon length was shortened （,P,<,0.05）， the expression of anti-inflammatory cytokines IL-4 and IL-10 decreased （,P,<,0.05）， and the expression levels of Beclin1 and LC3 protein and mRNA decreased significantly （,P,<,0.05） in the model group. According to the inter-group comparison between the model group and the CSD and mesalazine groups， the DAI score， CMDI score， pro-inflammatory cytokines IL-1β， IL-18 and P62 molecules decreased （,P,<,0.05）， the colon length significantly increased （,P,<,0.05）， and the expression levels of anti-inflammatory factors IL-4， IL-10， Beclin1 and LC3 significantly increased （,P,<,0.05） in the CSD group and mesalazine group. According to the inter-group comparison between the CSD group and the mesalazine group， the CMDI score increased （,P,<,0.05）， the expression of IL-1β， IL-18 and P62 increased （,P,<,0.05）， the expression of IL-4， IL-10， Beclin1 and LC3 decreased （,P,<,0.05）， and the differences in colon length as well as DAI score were not statistically significant （,P,>,0.05） in the CSD group.,Conclusion,2,CSD can reduce the colonic inflammation and pathological injury in UC model mice by promoting the expression of autophagy in colonic tissue.

关键词

溃疡性结肠炎复方苦参汤自噬炎症因子小鼠模型中药研究

Keywords

ulcerative colitisCompound Sophorae Decoctionautophagyinflammatory factorsmouse modeltraditional Chinese herbal medicine research

references

FEUERSTEIN J D， MOSS A C， FARRAYE F A. Ulcerative colitis［J］. Mayo Clin Proc， 2019， 94（7）： 1357-1373.

刘笃佳，王媛媛，马旭. 溃疡性结肠炎的流行病学研究进展［J］. 中国烧伤创疡杂志，2017， 29（3）： 214-217.

LV Q， XING Y， LIU J， et al. Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation［J］. Acta Pharm Sin B， 2021， 11（9）： 2880-2899.

QIU P， LIU L， FANG J， et al. Identification of pharmacological autophagy regulators of active ulcerative colitis［J］. Front Pharmacol， 2021， 12： 769718.

董亚兰，范恒. 复方苦参汤治疗溃疡性结肠炎102例临床分析［J］. 中西医结合研究，2016， 8（5）： 248-250.

冷雪媛，范恒，陈倩云. 范恒教授复方苦参汤治疗溃疡性结肠炎临床经验［J］. 光明中医， 2021， 36（18）： 3073-3075.

喻婷，胡德胜，楚思，等. 复方苦参汤联合美沙拉嗪对溃疡性结肠炎治疗效果及炎性因子水平的影响［J］. 现代生物医学进展，2021， 21（1）： 50-53.

XIE J， LI L， DENG S， et al. Slit2/Robo1 mitigates DSS-induced ulcerative colitis by activating autophagy in intestinal stem cell［J］. Int J Biol Sci， 2020， 16（11）： 1876-1887.

LI Q， CUI Y， XU B， et al. Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner［J］. Pharmacol Res， 2021， 170： 105694.

张林，徐若欣，陈颜. 中医对溃疡性结肠炎的治疗进展［J］. 中国处方药，2021， 19（10）： 132-134.

朱蕾蕾，李莉，顾志坚，等. 基于数据挖掘的中医内服及灌肠治疗溃疡性结肠炎方药规律分析［J］. 上海中医药杂志，2019， 53（7）： 10-14.

楚思. 复方苦参汤及EphB2-BMSC-Exo治疗溃疡性结肠炎的机制研究［D］. 武汉：华中科技大学，2022.

杨佳，范恒. 复方苦参汤对溃疡性结肠炎大鼠炎性反应和氧化应激的影响［J］. 中华中医药杂志，2017， 32（8）： 3457-3461.

朱凤，韦春珠，范恒，等. 复方苦参汤通过调节肠道Th1及Th17细胞分化缓解溃疡性结肠炎肠道损伤［J］. 华中科技大学学报（医学版），2022， 51（2）： 146-151.

ZHAO Y， LUAN H， JIANG H， et al. Gegen Qinlian decoction relieved DSS-induced ulcerative colitis in mice by modulating Th17/Treg cell homeostasis via suppressing IL-6/JAK2/STAT3 signaling［J］. Phytomedicine， 2021， 84： 153519.

CHEN X， ZHAO X， WANG H， et al. Prevent effects of lactobacillus fermentum HY01 on dextran sulfate sodium-induced colitis in mice［J］. Nutrients， 2017， 9（6）： 545.

MIZUSHIMA N. A brief history of autophagy from cell biology to physiology and disease［J］. Nat Cell Biol， 2018， 20（5）： 521-527.

LIN F， ZHU Y T， QIN Z H. Biomarkers of autophagy［J］. Adv Exp Med Biol， 2021， 1208： 265-287.

LARABI A， BARNICH N， NGUYEN H T T. New insights into the interplay between autophagy， gut microbiota and inflammatory responses in IBD［J］. Autophagy， 2020， 16（1）： 38-51.

SCHAAF M B， KEULERS T G， VOOIJS M A， et al. LC3/GABARAP family proteins： autophagy-（un）related functions［J］. FASEB J， 2016， 30（12）： 3961-3978.

FOERSTER E G， MUKHERJEE T， CABRAL-FERNANDES L， et al. How autophagy controls the intestinal epithelial barrier［J］. Autophagy， 2022， 18（1）： 86-103.

HOOPER K M， BARLOW P G， STEVENS C， et al. Inflammatory bowel disease drugs： a focus on autophagy［J］. J Crohns Colitis， 2017， 11（1）： 118-127.

Views

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanisms of Erlong Zuoci Wan alleviating damage to cochlear spiral ganglion neurons by upregulation of SIRT1 in mice with presbycusis

Effect of Modified Xuanbai Chengqi Decoction on intestinal flora and immunity of mice with mycoplasma pneumoniae pneumonia

Mechanism of Jianpi Jiedu Formula to inhibit epithelial mesenchymal transition of colorectal cancer through Hippo signaling pathway

Mechanism of astragaloside Ⅳ regulating exosome production and secretion and inhibiting metastasis of colorectal cancer

Effect of Shenge Recipe on oxidative stress and mitochondrial function of steatosis hepatocytes

Related Author

No data

Related Institution

School of Integrative Medicine Sciences， Shanghai University of Traditional Chinese Medicine

School of Traditional Chinese Medicine， Shanghai University of Traditional Chinese Medicine

Department of Pediatrics， Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Medical Oncology and Cancer Institute， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Medical Oncology & Cancer Institute of Integrative Medicine， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

⁰